UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004888
Receipt number R000005722
Scientific Title Warming igel a new supraglottic airway device shortens time to seal to the larynx?
Date of disclosure of the study information 2011/01/17
Last modified on 2011/10/27 15:23:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Warming igel a new supraglottic airway device shortens time to seal to the larynx?

Acronym

Comparison of the igel a new supraglottic airway device with or without warming

Scientific Title

Warming igel a new supraglottic airway device shortens time to seal to the larynx?

Scientific Title:Acronym

Comparison of the igel a new supraglottic airway device with or without warming

Region

Japan


Condition

Condition

Diseases which need operation under general anesthesia

Classification by specialty

Surgery in general Breast surgery Orthopedics
Urology Anesthesiology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

I-gel TM (Intersurgical Ltd, Wokingham,U.K.) is a new supraglottic airway device, non inflatable mask which is soft, gel like and transparent, made of thermoplastic elastomer. The mask changes its form based on each patient's laryngeal anatomy.The gel to be softened by the patient's temperature, air leakage may occur immediately after insertion of the device. This study is designed to investigate the usefulness of the I-gel which preheated to about body temperature in adults for the airway sealing pressure, inspiratory and expiratory tidal volume , ease of insertion, blood staining of the device, bronchospasm /laryngospasm , regurgitation / aspiration and hoarseness .

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

0,1,2,3,5,10,30and 60 minutes after i-gel insertion
Peak airway pressure
Inspiratory tidal volume
Expiratory tidal volume
Maximam gas leak pressure
ETCO2
SpO2

Key secondary outcomes

Mallampati classification
insertion time
Insertion:
cough,laryngeal spasm,gastric inflation,bleeding
postoperative complications:
nausea,vomiting,hoarseness,sore throat


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

to warm i-gel before using

Interventions/Control_2

control

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

ASA1-3
general anesthetized patients

Key exclusion criteria

full stomach
past history of gastrectomy and surgery of pharynx or larynx

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yumiko Kohno

Organization

Higashiomiya general hospital

Division name

Anestesiology

Zip code


Address

5-18,Higashiomiya,minuma-ku,Saitama city,Japan

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Higashiomiya general hospital

Division name

Anestesiology

Zip code


Address

5-18,Higashiomiya,minuma-ku,Saitama city,Japan

TEL

0486847111

Homepage URL


Email



Sponsor or person

Institute

Higashiomiya general hospital

Institute

Department

Personal name



Funding Source

Organization

Department of Anesthesiology, Higashiomiya general hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

ASAN Medical Center,Korea

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東大宮総合病院(埼玉県)


Other administrative information

Date of disclosure of the study information

2011 Year 01 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 11 Month 30 Day

Date of IRB


Anticipated trial start date

2011 Year 12 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 01 Month 17 Day

Last modified on

2011 Year 10 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005722


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name